Yin Xunliang, Xue Sha, Wang Haiqiang, Cheng Shaoyi, Feng Zheng, Guo Yize, Zhou Yongan, Zhao Zhengwei
Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Military Medical University, Xi'an, Shaanxi, China.
Department of Anesthesiology, The Second Affiliated Hospital of Xi'an Medical College, Xi'an, Shaanxi, China.
J Surg Res. 2023 May;285:107-113. doi: 10.1016/j.jss.2022.12.019. Epub 2023 Jan 16.
This study aims to retrospectively compare the efficacy and safety of subxiphoid and subcostal arch thoracoscopic resection (SR) and the median sternotomy (MS) for thymoma with myasthenia gravis (MG) via propensity-matched analysis.
We retrospectively analyzed 502 patients with thymoma and MG in Tangdu Hospital of the Fourth Military Medical University from December 2012 to December 2017. The patients were allocated to SR group (n = 424) and MS group (n = 78). Perioperative outcomes were compared between SR group and MS group by using propensity-matched analysis.
All SR and MS operations were accomplished successfully. Most postoperative outcomes between the two groups showed no significant difference such as remission of MG and postoperative complication (P > 0.05). There were statistically significant differences between MS group and SR group in operation time [(116.3 ± 33.7) min versus (52.2 ± 31.3) min], intraoperative blood loss [(145.2 ± 26.7) mL versus (51.2 ± 10.3) mL], chest drainage duration (3.4 d versus 0 d), days of hospital-stay (5.2 d versus 2.7 d), patient satisfaction score (5.9 ± 2.3 versus 8.7 ± 1.2), the incidence of complications and pain scores, with all P values < 0.05.
This study suggests that subxiphoid and subcostal arch thoracoscopic resection is a less invasive procedure with good safety and feasibility as compared with median sternotomy for thymoma with myasthenia gravis.
本研究旨在通过倾向评分匹配分析,回顾性比较剑突下和肋弓下胸腔镜切除术(SR)与正中胸骨切开术(MS)治疗重症肌无力(MG)合并胸腺瘤的疗效和安全性。
我们回顾性分析了2012年12月至2017年12月在第四军医大学唐都医院就诊的502例胸腺瘤合并MG患者。将患者分为SR组(n = 424)和MS组(n = 78)。采用倾向评分匹配分析比较SR组和MS组的围手术期结局。
所有SR和MS手术均成功完成。两组间大多数术后结局无显著差异,如MG缓解和术后并发症(P > 0.05)。MS组和SR组在手术时间[(116.3 ± 33.7)分钟对(52.2 ± 31.3)分钟]、术中出血量[(145.2 ± 26.7)毫升对(51.2 ± 10.3)毫升]、胸腔引流持续时间(3.4天对0天)、住院天数(5.2天对2.7天)、患者满意度评分(5.9 ± 2.3对8.7 ± 1.2)、并发症发生率和疼痛评分方面存在统计学显著差异,所有P值均< 0.05。
本研究表明,对于重症肌无力合并胸腺瘤,与正中胸骨切开术相比,剑突下和肋弓下胸腔镜切除术是一种侵入性较小的手术,具有良好的安全性和可行性。